JPRN-UMIN000000570未知未知
Follow-up study for localized prostate cancer treated by hormonal therapy or radical prostatectomy. - J-CaP IS-1 study
J-CaP study group0 个研究点目标入组 2,000 人开始时间: 2006年12月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 67years-old 至 76years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
PROstate cancer follow-up care in Secondary and Primary hEalth Care: PROSPEC study.Prostate cancer, survivorship, primary care, secondary care, follow-up, general practitioner, randomised controlled trialDutch: Prostaatcarcinoom, overlevingszorg, eerstelijnszorg, tweedelijnszorg, nazorg, huisarts, gerandomiseerd gecontroleerde trial.NL-OMON24717Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands390
招募中
不适用
Focal therapy for locally recurrent prostate cancerprostate cancerJPRN-UMIN000038761Tokyo Medical and Dental University100
进行中（未招募）
1 期
Study on patients with recurrence of prostate cancer with PET/MRRadically treated patient for prostate cancer presenting a biochemical recurrence of disease (PSA: > o = 0.2 ng/mL)MedDRA version: 21.1Level: LLTClassification code 10026389Term: Malignant neoplasm of prostateSystem Organ Class: 100000004864EUCTR2018-001036-21-ITOSPEDALE SAN RAFFAELE60
尚未招募
不适用
Focal therapy of recurrent prostate cancer after external beam radiation therapy using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technology (FOXPRO_RAD) – an initial pilot studyC61Malignant neoplasm of prostateDRKS00009020Klinik für Urologie, Universitätsmedizin Mannheim15
尚未招募
不适用
PROSPEC study; PROstate cancer follow-up care in Secondary and Primary hEalth Careprostate cancerNL-OMON48798ederlands Kanker Instituut390